AMGN vs NBIX
Amgen vs Neurocrine Biosciences — AI-powered side-by-side comparison
| Metric | AMGN | NBIX |
|---|---|---|
| AI Score | 57 | 66 |
| Price | $376.03 | $175.67 |
| P/E Ratio | 25.97× | 26.20× |
| ROE | 0.9% | 0.1% |
| Revenue Growth YoY | — | — |
| Gross Margin | 0.7% | 1.0% |
| Debt / Equity | 6.24× | 0.12× |
| Dividend Yield | 0.0% | 0.0% |
| RSI (14) | 69.5 | 56.8 |
| Beta | 0.403 | 0.386 |
| Expected Upside | +4.0% | — |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
AMGN Full Analysis
NBIX Full Analysis